Company Overview and News

15
Cobalt Miners News For The Month Of August 2018

2018-08-23 seekingalpha
Cobalt miner news - BHP seeking to add cobalt sulphate from Nickel West operation. China Molybdenum net profit set to surge between 271.21% and 295.16%.
SIE PIO CLA PANRF BLT CCZ PAN HAV MCR KBGCF CTM AXE ECSIF IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR CDU RGARF CHK MCRZY FTMDF KAT RER BBL CSSQF BHPLF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF GAL CZI AMSLF BPLNF HMI POS AUZ RNX GME FQVLF AQR PTNUF FT BHPBF HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM BHP CNJ AZRMF HLPCF BPL BHP OZL ARV

 
Umicore SA (UMICF) CEO Marc Grynberg on Q2 2018 Results - Earnings Call Transcript

2018-08-01 seekingalpha
Thank you. Good morning, everybody, and welcome to the presentation of Umicore's results for the first half of this year. I will cover developments in the business and the outlook for the full year before handing over to Filip who will take you through the financials. I will then wrap up before opening up the call to you for any questions that you might have.
UMICF UMICY MS UMI

2
SOITEC : SOITEC FAIT PART DE DÉCISIONS PRISES PAR SON CONSEIL D'ADMINISTRATION LORS DE SA RÉUNION DU 26 JUILLET 2018

2018-07-31 globenewswire
SOITEC FAIT PART DE DÉCISIONS PRISES PAR SON CONSEIL D'ADMINISTRATION LORS DE SA RÉUNION DU 26 JUILLET 2018
ADTTF IPGP UMICF UMICY UMI RNO INTC ATEYY

2
SOITEC : SOITEC ANNOUNCES DECISIONS TAKEN BY ITS BOARD OF DIRECTORS DURING ITS MEETING HELD ON JULY 26th, 2018

2018-07-31 globenewswire
SOITEC ANNOUNCES DECISIONS TAKEN BY ITS BOARD OF DIRECTORS DURING ITS MEETING HELD ON JULY 26th, 2018
ADTTF IPGP UMICF UMICY UMI RNO INTC ATEYY

17
Cobalt Miners News For The Month Of July 2018

2018-07-23 seekingalpha
Cobalt market news - Darton forecasts 40% growth in cobalt demand in 2018. Tony Southgate (ERG) says: "The cobalt boom is guaranteed for the next seven to 10 years."
SIE PIO CLA PANRF RIO CCZ PAN HAV MCR KBGCF CTM FCX AXE IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR SHERF CDU RGARF CHK MCRZY CLQ FTMDF KAT RIO RER CSSQF GMRSF CZN PGM GBLEF NZRIF RIO AZS GLCNF DLE HBNRF MEI PIONF CZI AMSLF BPLNF HMI POS AUZ RNX RTPPF GME RTNTF FQVLF AQR PTNUF FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM CNJ AZRMF HLPCF BPL BHP OZL ARV

4
‘Urban mining’ in S. Korea pulls rare battery materials from recycled tech (VIDEO)

2018-04-13 themalaymailonline
GUNSAN, April 13 — Workers at a rural South Korean factory are busy extracting some of the world’s most coveted metals, used in the batteries that power electric cars.
MALRY UMICF UMICY MALRF UMI MIN

4
'Urban mining' in South Korea pulls rare battery materials from recycled tech

2018-04-12 channelnewsasia
GUNSAN, South Korea: Workers at a rural South Korean factory are busy extracting some of the world's most coveted metals, used in the batteries that power electric cars.
MALRY UMICF UMICY MALRF UMI MIN

 
Electrifying Growth Catalysts

2018-04-06 seekingalpha
Umicore (OTCPK:UMICF) (OTCPK:UMICY) (EBR:UMI) is a long-term play on clean mobility and metal recycling. Its core activities are centered on three business areas: NMC-based battery materials, emission catalysts and recycling of some 20 elements. The firm is a leading player in the light-duty vehicles auto catalyst market, and the number-one provider of NMC (nickel-manganese cobalt) battery materials.
UMICF UMICY

208
Cobalt Miners News For The Month Of March 2018

2018-03-25 seekingalpha - 1
Cobalt spot price news - Spot prices rise 18.7% in the past month as inventory falls. The cobalt spot price is now over USD 40/lb, and approaching USD 100,000/tonne.
SIE PIO PANRF HAV PAN KBGCF MCR FCX ECSIF IGO VIC BAR AOU HIG PLM.RT TAKRF UMICF SNNAF FQM LGI MCRZF BXTMF MLX PSDNF POM CDU RGARF CHK VLKAF MCRZY FTMDF KAT RER CSSQF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF CZI AMSLF HMI POS AUZ RNX GME AAPL FQVLF AQR MBL PTNUF FT HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF KATFF MLXEF OZMLF PLM S CNJ AZRMF HLPCF BHP OZL ARV

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 90420M104